References
  1. Cancer Research UK http://www.cancerhelp.org.uk/about-cancer/cancer-questions/how-many-different-types-of-cancer-are-there
  2. Liver Cancer UK incidence statistics. September 2010 – Cancer Research UKNational Cancer Intelligence Network (NCIN) The excess burden of cancer in men in the UK. 

    http://info.cancerresearchuk.org/print/%20?files=CRUKMIG_100019754,CRUKMIG_ 100019755,CRUKMIG_100019756&parentfile=CRUKMIG_100019754 

  3. Ryder, SD. UK Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52(Suppl III): iii 1- iii 8.

  4. Ustundg, Y. Bayraktar,Y. Cholangiocarcinoma: A compact review of the literature. World Journal of Gastroenterology 2008;14(42):6458-6466.

  5. Khan,SA. Thomas, HC. Davidson, BR. Taylor-Robinson, SD. Cholangiocarcinoma. The Lancet 2005;366(9493):1303-14.

  6. World Gastroenterology Organisation Global Guideline. Hepatocellular carcinoma (HCC): a global perspective 2009.

  7. Gomaa, A I. Et al. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World Journal of Gastroenterology 2008;14(20):4300-4308.

  8. Robinson,PJ. The early detection of liver metastases. Cancer Imaging 2002;2:1-3.

  9. Stickel, F. Hellerbrand, C. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut 2010;59:1303-1307

  10. Ascha, MS. Et al. The incidence and risk factors of hepatocellular carcinoma in patients with non alcoholic steatohepatitis. Hepatology 2010;1972-1978.

  11. Blonski, W. Et al. Non-viral causes of hepatocellular carcinoma. World Journal of Gastroenterology 2010;16(29):3603-3615.

  12. Abdel-Hamid, NM. Recent insights on risk factors of hepatocellular carcinoma. World Journal of Hepatology 2009;1(1):3-7.

  13. Siegel, AB. Et al. Metabolic syndrome and hepatocellular carcinoma. Cancer 2009;5651 – 5661.

  14. Kuper, H. Et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. International Journal of Cancer 2000;85:498-502.

  15. Socas, L. Et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. British Journal of Sports Medicine 2005;39:e27.

  16. Mastertona, GS. Hayes, PC. Coffee and the liver: a potential treatment for liver disease? European Journal of Gastroenterology & Hepatology 2010;22 (11):1277-1283.

  17. Map of medicine health guide: Hepatocellular cancer.

  18. Khan, S.A. Et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document. Gut. 2002;51:vi1-vi19.

  19. Silva, MA. Et al. Surgery for hilar cholangiocarcinoma; a ten year experience of a tertiary referral centre in the UK. European Journal of Surgical Oncology 2005;31(5):533-539.

  20. John AR, Et al. Multivariate and univariate analysis of prognostic factors following resection in HCC: The Birmingham experience. Digestive Surgery 2006;23:103-109.

  21. Jarnagin, WR. Management of small Hepatocellular Carcinoma: A review of transplantation, resection and ablation. Ann Surg Oncol 2010;17:1226-1233.

  22. Gravante, G. Et al. Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies. J Gastrointest Surg 2010:1377-6.

  23. NHS Blood and transplant liver advisory group. Protocols and Guidelines for adults undergoing deceased donor liver transplantation in the UK, 2009. 

  24. Cancer Research UK. http://www.cancerhelp.org.uk/type/liver-cancer/treatment/statistics-and-outlook-for-liver-cancer

  25. Clinical Knowledge Summary: Liver cancer. www.cks.nhs.uk

  26. NICE Guidance. Treating secondary cancer of the liver by freezing (cryotherapy), 2010.

  27. NICE Guidance. Sorafenib for advanced hepatocellular (liver) cancer.

  28. NICE Guidance .Photodynamic therapy for bile duct cancer, 2005.

  29. Lau et al Salvage surgery following downstaging of unresectable hepatocellular carcinoma: a strategy to increase respectability. Annals of Surgical Oncology 14(12):3301-3309.

  30. Townsend, A, Et al. Selective internal radiation therapy for liver metastases from colorectal cancer (Review). The Cochrane Collaboration, 2009.

  31. Vente, MA. Et al. Yttrium-90 microsphere radioembolisation for the treatment of liver malignancies: a structured meta-analysis. European Radiology 2009;19(4):951-959.

  32. NICE Guidance. 93 Selective internal radiation for colorectal metastases in the liver, 2004.

  33. NICE Guidance. Treating primary liver cancer with microwave ablation, 2007.

  34. Llovet, JM. Bruix, JB. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008 48(4):1312-1327.

  35. Lachenmayer, A. Et al. Molecular approaches to treatment of hepatocellular carcinoma. Digestive and liver disease 2010;42 Suppl 3:S264-72.

  36. Zhu, AX. Systemic treatment of hepatocellular carcinoma: dawn of a new era?  Annals of surgical oncology 2010;17(5):1247-56.